...
首页> 外文期刊>Leukemia Research: A Forum for Studies on Leukemia and Normal Hemopoiesis >Elevated Fas/FasL system and endothelial cell microparticles are involved in endothelial damage in acute graft-versus-host disease: A clinical analysis
【24h】

Elevated Fas/FasL system and endothelial cell microparticles are involved in endothelial damage in acute graft-versus-host disease: A clinical analysis

机译:Fas / FasL系统升高和内皮细胞微粒参与急性移植物抗宿主病的内皮损伤:临床分析

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Acute graft-versus-host disease (aGVHD) is the major cause of early morbidity and mortality in allogeneic hematopoietic stem cell transplantation (allo-HSCT) recipients, but its mechanism remains not well understood. This study firstly compared dynamic change of Fas/Fas ligand (FasL) system in plasma and also in the surface of endothelial cell microparticles (EMPs) in aGVHD patients, pre-aGVHD patients (7, 14, 21 and 28 days after transplantation), non-aGVHD patients and normal controls. Plasma soluble FasL (sFasL) was detected by ELISA. Fas, FasL and EMPs were evaluated by Confocal microscopy and flow cytometric analysis respectively. Significantly higher levels of sFasL and EMPs were detected in the patients at the time of aGVHD attack. In addition, sFasL exhibited significant elevation but EMPs exhibited simultaneously decrease within the early phase (+21d) after allo-HSCT in pre-aGVHD group compared with non-aGVHD group. At +21d, there was a significant difference of sFasL and EMPs between pre-aGVHD group and non-aGVHD group. Moreover our present study firstly reported that EMPs expressed higher Fas antigen (Fas +-EMPs) in the patients with aGVHD. Therefore it can be inferred that EMPs may play protective roles through Fas in endothelial cell damage of aGVHD after allo-HSCT. This suggested monitoring EMPs and sFasL in the early phase after HSCT may be useful for the early diagnosis and forecast of aGVHD and it also provided new clues in understanding the pathogenesis of endothelial cell injury during aGVHD after allo-HSCT and meanwhile help identifying new drugs to circumvent it in clinic.
机译:急性移植物抗宿主病(aGVHD)是同种异体造血干细胞移植(allo-HSCT)受者早期发病和死亡的主要原因,但其机制仍不清楚。这项研究首先比较了aGVHD患者,aGVHD前患者(移植后7、14、21和28天)血浆和内皮细胞微粒(EMP)表面Fas / Fas配体(FasL)系统的动态变化,非aGVHD患者和正常对照。通过ELISA检测血浆可溶性FasL(sFasL)。 Fas,FasL和EMPs分别通过共聚焦显微镜和流式细胞术进行评估。在aGVHD发作时,患者中检测到sFasL和EMP的水平明显升高。此外,与非aGVHD组相比,aGVHD前组在allo-HSCT后早期(+ 21d)sFasL表现出显着升高,但EMPs同时下降。在+ 21d时,aGVHD前组和非aGVHD组之间的sFasL和EMP有显着差异。此外,我们目前的研究首先报道了EMPs在aGVHD患者中表达较高的Fas抗原(Fas + -EMPs)。因此,可以推断,同种异体造血干细胞移植后,EMPs通过Fas在aGVHD的内皮细胞损伤中起保护作用。这提示HSCT后早期监测EMPs和sFasL可能对aGVHD的早期诊断和预测有用,也为了解异基因-HSCT后aGVHD期间内皮细胞损伤的发病机理提供了新的线索,同时有助于鉴定新的药物来治疗aGVHD。在诊所避开它。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号